Ads
related to: yervoy cancer drug- Dosing & Administration
View Treatment Regimen For A HER2+
Advanced Gastric Cancer Therapy.
- Mechanism Of Action
Physicians: See How A Treatment For
HER2+ Advanced Gastric Cancer Works
- Official Physician Site
See If A HER2+ Advanced Gastric
Treatment Is An Option For Patients
- Resources & Support
Learn About Financial Assistance &
A Support Program For Your Patients
- Request A Representative
Connect With A Rep & Sign Up For
Updates To Learn About A Treatment.
- View Clinical Guidelines
Clinical Guidelines For HER2+
Advanced Gastric Cancer. Learn More
- Dosing & Administration
Search results
Bristol Myers drug combo fails to meet main goal in kidney cancer trial
Reuters via Yahoo News· 2 years agoYervoy and top selling cancer drug Opdivo - is already approved in the United States as a first line...
Bristol Myers' Opdivo-Yervoy combo meets main goal in liver cancer trial
Reuters via AOL· 2 months agoThe treatment, tested in patients with advanced hepatocellular carcinoma (HCC), met the main goal of...
Bristol Myers Squibb's Combo Therapy Shows Sustained Benefits Over Pfizer's Cancer Drug In Kidney...
Benzinga via Yahoo Finance· 4 months agoBristol Myers Squibb & Co (NYSE:BMY) announced that Opdivo (nivolumab) plus Yervoy (ipilimumab)...
IBD Stock Of The Day: Bristol Myers Eyes Breakout After $4.1 Billion Buyout
Investor's Business Daily· 2 years agoBristol Myers Squibb is the IBD Stock Of The Day as BMY stock bounds off its 50-day line, presenting...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 9 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
Bristol Myers Stock Yo-Yoes, Trying To Avoid A Fourth Day In The Red, On So-So Earnings
Investor's Business Daily· 3 months agoBristol Myers Squibb topped Wall Street's fourth-quarter expectations on Friday, but BMY stock...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 2 days agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer...
Investor's Business Daily· 11 months agoGerman biotechnology company BioNTech said Friday almost a third of patients with a hard-to-treat...
Bristol Myers (BMY) to Buy Cancer Drug-Maker RayzeBio for $4.1B
Zacks via Yahoo Finance· 5 months agoBristol Myers (BMY) is set to acquire RayzeBio for $4.1 billion to strengthen and diversify its...
Iovance (IOVA) to Buy Clinigen's Cancer Drug, Stock Up 11.6%
Zacks via Yahoo Finance· 1 year agoIovance (IOVA) to acquire worldwide rights to an IL-2 product already approved by FDA for two cancer...
Ads
related to: yervoy cancer drug